Title | Type | SJR | H index | Total Docs. (2017) | Total Docs. (3years) | Total Refs. (2017) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2017) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Expert Opinion on Emerging Drugs | journal | 1.109 Q1 | 54 | 28 | 129 | 3050 | 393 | 121 | 3.39 | 108.93 | |
2 | Cochrane Database of Systematic Reviews | journal | 2.347 Q1 | 327 | 1348 | 4691 | 122482 | 22768 | 4653 | 4.44 | 90.86 | |
3 | Advances in Pharmacological and Pharmaceutical Sciences | journal | 46 | 5 | 70 | 447 | 173 | 70 | 2.58 | 89.40 | ||
4 | Expert Review of Neurotherapeutics | journal | 1.006 Q2 | 98 | 118 | 398 | 10360 | 1250 | 373 | 3.25 | 87.80 | |
5 | Expert Opinion on Orphan Drugs | journal | 0.279 Q3 | 27 | 97 | 383 | 8193 | 251 | 371 | 0.75 | 84.46 | |
6 | CNS Drugs | journal | 1.635 Q1 | 129 | 85 | 261 | 6852 | 1259 | 256 | 4.63 | 80.61 | |
7 | Expert Review of Clinical Pharmacology | journal | 0.833 Q2 | 60 | 127 | 314 | 10221 | 816 | 296 | 2.50 | 80.48 | |
8 | Expert Opinion on Investigational Drugs | journal | 1.166 Q1 | 117 | 137 | 398 | 10419 | 1361 | 387 | 3.58 | 76.05 | |
9 | Drugs | journal | 1.547 Q1 | 188 | 163 | 472 | 11786 | 2433 | 463 | 5.16 | 72.31 | |
10 | Expert Opinion on Drug Safety | journal | 1.112 Q1 | 90 | 139 | 510 | 9936 | 1737 | 490 | 3.31 | 71.48 | |
11 | Journal of Biomedical Science | journal | 1.302 Q1 | 110 | 95 | 289 | 6787 | 1043 | 289 | 3.55 | 71.44 | |
12 | Expert Opinion on Pharmacotherapy | journal | 0.909 Q2 | 93 | 207 | 732 | 14623 | 2161 | 707 | 3.10 | 70.64 | |
13 | Expert Review of Anticancer Therapy | journal | 0.804 Q2 | 85 | 120 | 430 | 8365 | 856 | 403 | 2.10 | 69.71 | |
14 | BioDrugs | journal | 1.038 Q2 | 79 | 45 | 131 | 3062 | 513 | 125 | 4.40 | 68.04 | |
15 | Journal of Psychopharmacology | journal | 1.939 Q1 | 135 | 158 | 402 | 10619 | 1715 | 374 | 4.59 | 67.21 | |
16 | Therapeutic Advances in Vaccines and Immunotherapy | journal | 13 | 4 | 0 | 241 | 0 | 0 | 0.00 | 60.25 | ||
17 | Drugs and Aging | journal | 1.072 Q2 | 109 | 87 | 273 | 5126 | 806 | 263 | 2.66 | 58.92 | |
18 | International Journal of Neuropsychopharmacology | journal | 1.808 Q1 | 125 | 111 | 514 | 6468 | 2277 | 502 | 4.50 | 58.27 | |
19 | Paediatric Drugs | journal | 0.814 Q2 | 70 | 58 | 143 | 3378 | 372 | 136 | 2.41 | 58.24 | |
20 | Journal of Pharmaceutical Health Care and Sciences | journal | 10 | 1 | 31 | 58 | 30 | 30 | 0.97 | 58.00 | ||
21 | Clinical Pharmacokinetics | journal | 1.482 Q1 | 184 | 122 | 301 | 6990 | 1370 | 272 | 4.16 | 57.30 | |
22 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 1.272 Q1 | 57 | 64 | 175 | 3550 | 510 | 169 | 2.61 | 55.47 | |
23 | American Journal of Cardiovascular Drugs | journal | 0.951 Q2 | 60 | 47 | 128 | 2530 | 376 | 121 | 2.88 | 53.83 | |
24 | npj Vaccines | journal | 2.269 Q1 | 47 | 34 | 16 | 1814 | 46 | 15 | 2.88 | 53.35 | |
25 | Expert Review of Pharmacoeconomics and Outcomes Research | journal | 0.738 Q2 | 61 | 63 | 278 | 3202 | 478 | 265 | 1.67 | 50.83 | |
26 | Acta Pharmacologica Sinica | journal | 1.173 Q1 | 117 | 145 | 478 | 7350 | 1568 | 474 | 3.43 | 50.69 | |
27 | Molecular Therapy - Oncolytics | journal | 1.193 Q1 | 42 | 34 | 66 | 1695 | 241 | 64 | 3.87 | 49.85 | |
28 | Fundamental and Clinical Pharmacology | journal | 0.688 Q2 | 85 | 69 | 201 | 3327 | 454 | 200 | 2.26 | 48.22 | |
29 | Therapeutic Advances in Cardiovascular Disease | journal | 0.535 Q2 | 41 | 28 | 107 | 1312 | 163 | 95 | 1.71 | 46.86 | |
30 | Therapeutic Advances in Respiratory Disease | journal | 1.081 Q2 | 50 | 38 | 100 | 1761 | 353 | 93 | 3.74 | 46.34 | |
31 | CNS Neuroscience and Therapeutics | journal | 1.380 Q1 | 91 | 99 | 402 | 4502 | 1306 | 317 | 3.04 | 45.47 | |
32 | Pharmaceutical Medicine | journal | 0.187 Q3 | 25 | 34 | 75 | 1474 | 45 | 63 | 0.52 | 43.35 | |
33 | Human Psychopharmacology | journal | 1.128 Q1 | 86 | 69 | 170 | 2986 | 516 | 170 | 2.93 | 43.28 | |
34 | Clinical Drug Investigation | journal | 0.719 Q2 | 67 | 113 | 296 | 4731 | 643 | 287 | 2.09 | 41.87 | |
35 | npj Breast Cancer | journal | 46 | 48 | 40 | 2007 | 146 | 37 | 3.65 | 41.81 | ||
36 | Orphanet Journal of Rare Diseases | journal | 1.413 Q1 | 136 | 187 | 573 | 7778 | 2226 | 567 | 3.83 | 41.59 | |
37 | Drug Safety | journal | 1.447 Q1 | 140 | 115 | 304 | 4725 | 1079 | 258 | 3.52 | 41.09 | |
38 | AIDS Research and Therapy | journal | 1.080 Q2 | 49 | 60 | 124 | 2461 | 304 | 123 | 2.47 | 41.02 | |
39 | Therapeutic Advances in Drug Safety | journal | 1.494 Q1 | 46 | 35 | 71 | 1424 | 333 | 52 | 2.56 | 40.69 | |
40 | Biopharmaceutics and Drug Disposition | journal | 0.551 Q2 | 65 | 50 | 148 | 1963 | 304 | 146 | 1.68 | 39.26 | |
41 | Trials | journal | 1.291 Q1 | 98 | 612 | 1682 | 23937 | 4021 | 1652 | 2.18 | 39.11 | |
42 | Cardiovascular Therapeutics | journal | 1.075 Q2 | 54 | 71 | 154 | 2744 | 394 | 149 | 2.32 | 38.65 | |
43 | British Journal of Clinical Pharmacology | journal | 1.543 Q1 | 167 | 298 | 841 | 11056 | 3196 | 731 | 3.63 | 37.10 | |
44 | BMC pharmacology & toxicology | journal | 0.785 Q2 | 43 | 82 | 180 | 3011 | 437 | 177 | 1.97 | 36.72 | |
45 | Antimicrobial Resistance and Infection Control | journal | 1.573 Q1 | 66 | 126 | 149 | 4237 | 557 | 145 | 3.75 | 33.63 | |
46 | Drugs and Therapy Perspectives | journal | 0.115 Q4 | 13 | 82 | 224 | 2556 | 28 | 222 | 0.15 | 31.17 | |
47 | Journal of Antimicrobial Chemotherapy | journal | 2.419 Q1 | 221 | 549 | 1671 | 17093 | 7930 | 1408 | 4.57 | 31.13 | |
48 | Journal of Clinical Pharmacy and Therapeutics | journal | 0.722 Q2 | 81 | 128 | 358 | 3863 | 728 | 351 | 1.91 | 30.18 | |
49 | Pharmacoepidemiology and Drug Safety | journal | 1.329 Q1 | 109 | 195 | 538 | 5867 | 1251 | 491 | 2.15 | 30.09 | |
50 | Psychiatry and Clinical Psychopharmacology | journal | 24 | 77 | 199 | 2292 | 78 | 157 | 0.28 | 29.77 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®